STOCK TITAN

CytoDyn to Hold Webcast to Provide a Company Update

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

CytoDyn Inc. (OTCQB: CYDY) announced an upcoming webcast for the investment community scheduled on April 11, 2023, at 1:00 PM PT / 4:00 PM ET. The update will feature key executives, including Board Chair Tanya Urbach and President Cyrus Arman, discussing the company’s progress and the potential of leronlimab, a CCR5 antagonist. Questions can be submitted prior to the event until Noon PT on April 7, 2023, and will be addressed during the presentation if appropriate. A replay will be available approximately one hour after the event until May 11, 2023.

Positive
  • Upcoming webcast showcases leadership engagement with investors.
  • Discussion to center on leronlimab's potential, highlighting ongoing development efforts.
Negative
  • None.

VANCOUVER, Washington, April 05, 2023 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Tanya Urbach, Board Chair, Cyrus Arman, President, Antonio Migliarese, Chief Financial Officer, and Scott Hansen, our newly appointed Head of Research and Basic Science, will host an investment community webcast to provide a Company update on Tuesday, April 11, 2023.

Following the update, questions submitted prior to the webcast as directed below will be addressed to the extent appropriate.

Date:  Tuesday, April 11, 2023
Time:  1:00 pm PT / 4:00 pm ET
Access:  https://event.choruscall.com/mediaframe/webcast.html?webcastid=1VcOPtAY
Questions:  Please submit any questions prior to the webcast, and not later than Noon PT, Friday, April 7, 2023. Questions can be submitted via email to: ir@cytodyn.com. Per CytoDyn’s current policy, the presenters will not be able to take live questions during the webcast.

This is a livestream presentation. Participants are encouraged to login early prior to the start of the event. The replay will be available approximately 60 minutes after the conclusion of the webcast and can be accessed via the above link until May 11, 2023.

CONTACTS
Investors:
Cristina De Leon
Office: 360.980.8524
ir@cytodyn.com


FAQ

What is the date and time of CytoDyn's upcoming investor webcast?

The investor webcast is scheduled for April 11, 2023, at 1:00 PM PT / 4:00 PM ET.

Who will present during the CytoDyn investment community webcast?

Tanya Urbach, Cyrus Arman, Antonio Migliarese, and Scott Hansen will present during the webcast.

How can I submit questions for the CytoDyn webcast?

Questions can be submitted via email to ir@cytodyn.com before Noon PT on April 7, 2023.

When will the replay of the CytoDyn webcast be available?

The replay will be available approximately 60 minutes after the conclusion of the webcast until May 11, 2023.

CYTODYN INC

OTC:CYDY

CYDY Rankings

CYDY Latest News

CYDY Stock Data

134.18M
1.21B
0.78%
0.03%
Biotechnology
Healthcare
Link
United States of America
Vancouver